Related Experiment Video
Updated: Jun 11, 2025
13:36
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
19.4K
MicroRNAs as Biomarkers of Brain Tumor
Wojciech Jelski1, Barbara Mroczko1,2
1Department of Biochemical Diagnostics, Medical University, Bialystok, Poland.
Cancer Management and Research
|October 9, 2024
Summary
Researchers are exploring microRNAs (a type of small RNA molecule) as sensitive, low-cost biomarkers for early brain tumor detection. These microRNAs in bodily fluids could significantly improve diagnosis and patient survival rates.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Brain tumors represent a significant oncological challenge, often diagnosed late due to current diagnostic limitations.
- Early detection of brain tumors is crucial for effective treatment and improved patient outcomes.
- There is a need for accessible and sensitive methods to identify cancer biomarkers.
Purpose of the Study:
- To review the diagnostic potential of microRNAs as biomarkers for brain tumors.
- To explore the role of microRNA expression in cerebrospinal fluid and blood for brain tumor diagnosis.
- To assess the prospects of microRNAs in enabling early diagnosis and enhancing survival in brain tumor patients.
Main Methods:
- Literature review of studies investigating microRNA expression in brain tumor patients.
- Analysis of microRNA changes in cerebrospinal fluid and blood samples.
- Evaluation of microRNAs as potential diagnostic biomarkers.
Main Results:
- MicroRNA expression levels in body fluids correlate with the presence of cancer.
- Altered microRNA profiles have been observed in cerebrospinal fluid and blood of brain tumor patients.
- MicroRNAs show promise as sensitive indicators for early brain tumor detection.
Conclusions:
- MicroRNAs are emerging as valuable biomarkers for the early diagnosis of brain tumors.
- Utilizing microRNAs can facilitate timely treatment interventions, thereby improving patient prognosis.
- Further research into microRNA-based diagnostics holds significant potential for neuro-oncology.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K